Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

GLG News by Physicians (Germany)

Volker Hoffmann, Partner/Owner

Volker HoffmannPartner/OwnerDiagnostic Imaging Center What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

NSF (Nephrogenic Systemic Fibrosis) - Gadoxetic Acid (Primovist)

October 9, 2007

Study Finds NSF More Common Than Previously Reported | www.dimag.com

Nephrogenic systemic fibrosis is becoming a severe problem for radiologist and industry as it may prevent physicians from using gadolinium containing contrast agents fearing that they induce nephrogenic systemic fibrosis even in patients without known kidney disease. A stable contrast agent with almost no release of gadolinium may be a solution: gadoxetic acid, sold in Europe and Asia as Primovist.

Volker Hoffmann, Partner/Owner

Volker HoffmannPartner/OwnerDiagnostic Imaging Center What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

IMDS - CTML - Value without contrast agents?

May 14, 2007

Imaging Diagnostic Systems Breast Scanner Performance Upgrade Program Nearing Completion | www.medicalnewstoday.com

The recent upgrade of the Computed Tomography Laser Mammography (CTLM(R)) system will only added minor details. The question whether this system without any contrast agent is of any value has not been answered so far.

Volker Hoffmann, Partner/Owner

Volker HoffmannPartner/OwnerDiagnostic Imaging Center What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Impropved pancreatic duct imaging in MR - small market for Secretin

May 14, 2007

Repligen Reports Positive Phase 2 Clinical Trial Results Of Secretin For MRI Imaging Of The Pancreas | www.medicalnewstoday.com

Pancreatic duct imaging is currently done with a heavily weighted T2 sequence that requires water in the duct for imaging. Increased production of pancreatic juice may make imaging easier. This is however a very small niche market which by itself will not allow survival of RG1068.

Page : 11 to 3 of 3

Leading institutions connect with members of the Healthcare councils through GLG

Most Popular Healthcare News